Your browser doesn't support javascript.
loading
Consensus on Contouring Primary Breast Tumors on MRI in the Setting of Neoadjuvant Partial Breast Irradiation in Trials.
Vasmel, Jeanine E; Groot Koerkamp, Maureen L; Kirby, Anna M; Russell, Nicola S; Shaitelman, Simona F; Vesprini, Danny; Anandadas, Carmel N; Currey, Adam; Keller, Brian M; Braunstein, Lior Z; Han, Kathy; Kotte, Alexis N T J; de Waard, Stephanie N; Philippens, Marielle E P; Houweling, Antonetta C; Verkooijen, Helena M; van den Bongard, H J G Desiree.
Afiliação
  • Vasmel JE; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, the Netherlands. Electronic address: j.e.vasmel@umcutrecht.nl.
  • Groot Koerkamp ML; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, the Netherlands.
  • Kirby AM; Royal Marsden NHS Foundation Trust/The Institute of Cancer Research, Sutton, England, United Kingdom.
  • Russell NS; Department of Radiation Oncology, AVL/NKI, Amsterdam, the Netherlands.
  • Shaitelman SF; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Vesprini D; Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
  • Anandadas CN; The Christie NHS Foundation Trust, Manchester, England, United Kingdom.
  • Currey A; Department of Radiation Oncology, Medical College of Wisconsin, Wauwatosa, Wisconsin.
  • Keller BM; Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
  • Braunstein LZ; Memorial Sloan-Kettering Cancer Center, New York, New York.
  • Han K; Radiation Medicine Program, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
  • Kotte ANTJ; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, the Netherlands.
  • de Waard SN; Department of Radiology, University Medical Center Utrecht, Utrecht, the Netherlands.
  • Philippens MEP; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, the Netherlands.
  • Houweling AC; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, the Netherlands.
  • Verkooijen HM; Imaging Division, University Medical Center Utrecht, Utrecht, the Netherlands; Utrecht University, Utrecht, The Netherlands.
  • van den Bongard HJGD; Department of Radiation Oncology, Amsterdam University Medical Center, Amsterdam, the Netherlands.
Pract Radiat Oncol ; 10(6): e466-e474, 2020.
Article em En | MEDLINE | ID: mdl-32315784
ABSTRACT

PURPOSE:

Our purpose was to present and evaluate expert consensus on contouring primary breast tumors on magnetic resonance imaging (MRI) in the setting of neoadjuvant partial breast irradiation in trials. METHODS AND MATERIALS Expert consensus on contouring guidelines for target definition of primary breast tumors on contrast-enhanced MRI in trials was developed by an international team of experienced breast radiation oncologists and a dedicated breast radiologist during 3 meetings. At the first meeting, draft guidelines were developed through discussing and contouring 2 cases. At the second meeting 6 breast radiation oncologists delineated gross tumor volume (GTV) in 10 patients with early-stage breast cancer (cT1N0) according to draft guidelines. GTV was expanded isotropically (20 mm) to generate clinical target volume (CTV), excluding skin and chest wall. Delineations were reviewed for disagreement and guidelines were clarified accordingly. At the third meeting 5 radiation oncologists redelineated 6 cases using consensus-based guidelines. Interobserver variation of GTV and CTV was assessed using generalized conformity index (CI). CI was calculated as the sum of volumes each pair of observers agreed upon, divided by the sum of encompassing volumes for each pair of observers.

RESULTS:

For the 2 delineation sessions combined, mean GTV ranged between 0.19 and 2.44 cm3, CI for GTV ranged between 0.28 and 0.77, and CI for CTV between 0.77 and 0.94. The largest interobserver variation in GTV delineations was observed in cases with extended tumor spiculae, blood vessels near or markers within the tumor, or with increased enhancement of glandular breast tissue. Consensus-based guidelines stated to delineate all visible tumors on contrast enhanced-MRI scan 1 to 2 minutes after contrast injection and if a marker was inserted in the tumor to include this.

CONCLUSIONS:

Expert-based consensus on contouring primary breast tumors on MRI in trials has been reached. This resulted in low interobserver variation for CTV in the context of a uniform 20 mm GTV to CTV expansion margin.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Terapia Neoadjuvante Tipo de estudo: Guideline Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Terapia Neoadjuvante Tipo de estudo: Guideline Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article